Search research articles
Contact Us
Filters
Showing results (11-20 of 120) with videos related to
Page
of 12
Sort By:
International Journal of Molecular Sciences
|
February 11, 2016
Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies
Irene López González, Paula Garcia-Esparcia, Franc Llorens, et al.
Current Neurology and Neuroscience Reports
|
March 22, 2017
Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations
Franc Llorens, Juan-José Zarranz, Andre Fischer, et al.
The Biochemical Journal
|
October 18, 2005
The N-terminal domain of the human eIF2beta subunit and the CK2 phosphorylation sites are required for its function
Franc Llorens, Anna Duarri, Eduard Sarró, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
August 8, 2018
Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson's disease dementia
Karin Gmitterová, Joanna Gawinecka, Franc Llorens, et al.
FEBS Letters
|
July 19, 2002
PP1/PP2A phosphatases inhibitors okadaic acid and calyculin A block ERK5 activation by growth factors and oxidative stress
Lourdes Garcia, Fatima Garcia, Franc Llorens, et al.
Molecular Neurobiology
|
February 12, 2018
Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases
Anna Villar-Piqué, Matthias Schmitz, Niccolò Candelise, et al.
Archives of Biochemistry and Biophysics
|
October 4, 2002
Persistent nuclear accumulation of protein kinase CK2 during the G1-phase of the cell cycle does not depend on the ERK1/2 pathway but requires active protein synthesis
Francesc A Miro, Franc Llorens, Nerea Roher, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 26, 2016
Mitochondrial DNA differentiates Alzheimer's disease from Creutzfeldt-Jakob disease
Petar Podlesniy, Franc Llorens, Ewa Golanska, et al.
Aging
|
September 15, 2018
YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
Pol Andrés-Benito, Raúl Domínguez, Maria J Colomina, et al.
Aging
|
November 5, 2021
Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
Pol Andrés-Benito, Raúl Domínguez, Maria J Colomina, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 120) with videos related to
Sort By:
Page
of 12
International Journal of Molecular Sciences
|
February 11, 2016
Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies
Irene López González, Paula Garcia-Esparcia, Franc Llorens, et al.
Current Neurology and Neuroscience Reports
|
March 22, 2017
Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations
Franc Llorens, Juan-José Zarranz, Andre Fischer, et al.
The Biochemical Journal
|
October 18, 2005
The N-terminal domain of the human eIF2beta subunit and the CK2 phosphorylation sites are required for its function
Franc Llorens, Anna Duarri, Eduard Sarró, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
August 8, 2018
Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson's disease dementia
Karin Gmitterová, Joanna Gawinecka, Franc Llorens, et al.
FEBS Letters
|
July 19, 2002
PP1/PP2A phosphatases inhibitors okadaic acid and calyculin A block ERK5 activation by growth factors and oxidative stress
Lourdes Garcia, Fatima Garcia, Franc Llorens, et al.
Molecular Neurobiology
|
February 12, 2018
Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases
Anna Villar-Piqué, Matthias Schmitz, Niccolò Candelise, et al.
Archives of Biochemistry and Biophysics
|
October 4, 2002
Persistent nuclear accumulation of protein kinase CK2 during the G1-phase of the cell cycle does not depend on the ERK1/2 pathway but requires active protein synthesis
Francesc A Miro, Franc Llorens, Nerea Roher, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 26, 2016
Mitochondrial DNA differentiates Alzheimer's disease from Creutzfeldt-Jakob disease
Petar Podlesniy, Franc Llorens, Ewa Golanska, et al.
Aging
|
September 15, 2018
YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
Pol Andrés-Benito, Raúl Domínguez, Maria J Colomina, et al.
Aging
|
November 5, 2021
Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
Pol Andrés-Benito, Raúl Domínguez, Maria J Colomina, et al.
Page
of 12